Scienture Holdings, Inc. last reported quarterly results on Oct 19, 2026, for Q3 FY2026 (the quarter ended Sep 30, 2026). It usually reports 19–52 days after a quarter ends. Based on that pattern, the next release is estimated for around Feb 19, 2027.
Results for Q4 FY2026, the quarter ending around Dec 31, 2026. Expected on a Friday. Based on how many days after a quarter ends the company has reported recently. This is an estimate, not a date the company has announced.
Release dates are when the company filed its earnings announcement with the SEC (Form 8-K, Item 2.02); select a date to open the filing. It usually reports 19–52 days after a quarter ends. Figures are USD in millions, except EPS. The colored percent is the change from the same quarter a year earlier. Until a quarter's 10-Q or 10-K figures reach the SEC's data, they come from the earnings press release, and are shown only when its year-ago numbers match the filed ones. A dash means the figure could not be confirmed yet.
| Released | Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|---|
|
Oct 19, 2026
19 days after quarter end
|
Q3 FY2026
ended Sep 30, 2026
|
—
|
—
|
—
|
|
Aug 20, 2026
51 days after quarter end
|
Q2 FY2026
ended Jun 30, 2026
|
0
|
-3
+58.0%
|
-0.07
+85.4%
|
|
May 22, 2026
52 days after quarter end
|
Q1 FY2026
ended Mar 31, 2026
|
0
+449.1%
|
-3
-11.0%
|
-0.08
+75.8%
|
|
May 15, 2023
45 days after quarter end
|
—
ended Mar 31, 2023
|
—
|
—
|
—
|
|
Nov 7, 2022
38 days after quarter end
|
—
ended Sep 30, 2022
|
—
|
—
|
—
|
|
Jul 25, 2022
25 days after quarter end
|
—
ended Jun 30, 2022
|
—
|
—
|
—
|
|
May 9, 2022
39 days after quarter end
|
—
ended Mar 31, 2022
|
—
|
—
|
—
|
|
Oct 25, 2021
25 days after quarter end
|
—
ended Sep 30, 2021
|
—
|
—
|
—
|
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- SCNX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Commack, NY
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1382574
- Former names
- TRxADE HEALTH, INC (until Aug 28, 2024); TRXADE GROUP, INC. (until May 28, 2021); XCELLINK INTERNATIONAL INC. (until Jan 31, 2014); Bluebird Exploration Co. (until Dec 10, 2008)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.